Medicines and health technology adoption

Life science innovation demands significant investment, robust clinical evidence and regulatory approval — yet even with these in place, progress can stall when it reaches everyday clinical practice. In practice, adoption often slows for a number of practical reasons. Clinical guidance can be hard to apply within everyday workflows, identifying eligible patients at scale remains challenging and uptake varies across regions. At the same time, clinicians are working under significant pressure with limited time and visibility. These challenges aren’t driven by a lack of clinical intent. They reflect the realities of a stretched, fragmented healthcare system — where even proven innovations can struggle to reach the patients who would benefit most. Where innovation slows

4

5